Ravi C Dara Shares WHO’s Phase A guidance for PBM from ISBT
Ravi C Dara, Consultant Physician Transfusion medicine at Sheikh Shakhbout Medical City, reposted from ISBT on LinkedIn:
”Better outcomes, fewer transfusions – Optimizing outcomes while reducing transfusions – WHO‘s Phase A guidance is here”
Quoting International Society of Blood Transfusion (ISBT)‘s post:
”The Patient Blood Management subgroup of the ISBT Clinical Transfusion Working Party is dedicated to spreading awareness on PBM and to help support its wider implementation.
This week, we’re shining a light on Patient Blood Management (PBM) and each day, we’ll explore a different phase of the PBM system, sharing diverse perspectives on who can benefit from it.
Patient blood management (PBM) is a new paradigm to manage and preserve an individual’s own blood in health and illness and highlighted as a patient-centered approach aimed at improving patient outcomes with reduced morbidity, mortality and length of hospital stay.
For Day 1, we’re highlighting Phase A of the WHO Implementation Guidance, focusing on the aims and initial steps involved in establishing PBM within healthcare settings.”
Stay updated with Hemostasis Today.
-
Jan 24, 2026, 15:54Nicolas Nesseler on How Common and Serious is Post-Op Bleeding After Heart Transplantation
-
Jan 24, 2026, 15:43Roey Tagansky on Tu Youyou and the Rediscovery That Defeated Malaria
-
Jan 24, 2026, 15:27Mavis Agnes Kisakye on Community Impact at HFU
-
Jan 24, 2026, 15:15Jo Jewell Announces Novartis Foundation and Novo Nordisk Collaboration
-
Jan 24, 2026, 15:02Todd Davenport on The Impacts of Long COVID
-
Jan 24, 2026, 14:47Seth D Ginsberg: Last Month, Something Meaningful Happened in Tokyo
-
Jan 24, 2026, 14:33Heghine Khachatryan on New Insights Into Bleeding Mechanisms in Acquired Hemophilia A
-
Jan 24, 2026, 14:21Mamta Soni Shares Highlights from CBC Chennai 2026
-
Jan 24, 2026, 13:52Larysa Mykhailova on Characterization of Allogeneic Platelet Gel